Pediatric Nephrology

, Volume 28, Issue 2, pp 295–303 | Cite as

Hyperlipidemia, oxidative stress, and intima media thickness in children with chronic kidney disease

  • Jelena Kotur-Stevuljević
  • Amira Peco-Antić
  • Slavica Spasić
  • Aleksandra Stefanović
  • Dušan Paripović
  • Mirjana Kostić
  • Dragan Vasić
  • Ana Vujović
  • Zorana Jelić-Ivanović
  • Vesna Spasojević-Kalimanovska
  • Danijela Kornic-Ristovski
Original Article



The roles of dyslipidemia and oxidative stress in the early phases of atherosclerosis were tested in children with chronic kidney disease (CKD). Intima media thickness of common carotid arteries (cIMT) is used as a measure of early atherosclerosis.


Fifty-two pediatric CKD patients were enrolled in the study (10 with chronic renal failure [CRF], 22 with a renal transplant [RT], 20 with chronic hemodialysis (cHD) patients, and 36 healthy children (control group, CG). Lipid status, oxidative stress, and paraoxonase 1 (PON1) status were assessed. cIMT was measured by ultrasound, adjusted for age and sex, and presented as standard deviation scores (SDS).


Children with CKD had disturbed lipid content, which was most pronounced in cHD children, with higher free cholesterol and triglycerides compared with healthy children. Oxidative stress was markedly increased (malodialdehyde [MDA, μmol/L]: CRF 1.50 ± 0.26, RT 1.55 ± 0.40, cHD 1.77 ± 0.34, CG 0.97 ± 0.33, p < 0.001) and antioxidative defense was compromised (superoxide dismutase [SOD, U/L]: CG 120 ± 21, CRF 84 ± 25, RT 93 ± 12, cHD 119 ± 37, p < 0.001). Multiple linear regression analysis showed that a model that included disease duration, blood pressure, urea, lipid, and oxidative status parameters accounted for more than 90% of the variability of cIMT-SDS.


Early atherosclerosis in CKD children is caused, at least in part, by dyslipidemia and oxidative stress. Monitoring of vessel wall changes, along with assessment of oxidative stress status and high density lipoprotein (HDL) functionality is necessary to ensure better therapeutic strategies for delaying atherosclerotic changes in their asymptomatic phase.


Oxidative stress Hyperlipidemia Paraoxonase Intima media thickness 


  1. 1.
    Chavers BM, Li S, Collins AJ, Hrzog CA (2002) Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int 62:648–653PubMedCrossRefGoogle Scholar
  2. 2.
    Litwin M, Grenda R, Prokurat S, Abuauba M, Latoszyñska J, Jobs K, Boguszewska-Baczkowska A, Wawer ZT (2001) Survival and causes of death in children on hemodialysis and continuous ambulatory peritoneal dialysis. Pediatr Nephrol 16:996–1001PubMedCrossRefGoogle Scholar
  3. 3.
    McDonald SP, Craig JC (2004) Long-term survival of children with end-stage renal disease. N Engl J Med 350:2654–2662PubMedCrossRefGoogle Scholar
  4. 4.
    Litwin M, Wuhl E, Jourdan C, Trelewicz J, Niemirska A, Fahr K, Jobs K, Grenda R, Wawer ZT, Rajszys P, Troger J, Mehls O, Schaefer F (2005) Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. Am Soc Nephrol 16:1494–1500CrossRefGoogle Scholar
  5. 5.
    Okamura DM, Himmelfarb J (2009) Tipping the redox balance of oxidative stress in fibrogenic pathways in chronic kidney disease. Pediatr Nephrol 24:2309–2319PubMedCrossRefGoogle Scholar
  6. 6.
    Vaziri ND (2006) Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol 290:262–272CrossRefGoogle Scholar
  7. 7.
    Wilson PWF, Larson MG, Castelli WP (1994) Triglycerides, HDL cholesterol and coronary artery disease: a Framingham update on their interrelations. Can J Cardiol 10:5–9Google Scholar
  8. 8.
    Watson AD, Berliner JA, Hama SY, La Du BN, Faull KF, Fogelman AM, Navab M (1995) Protective effect of high-density lipoprotein associated paraoxonase: inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 96:2882–2891PubMedCrossRefGoogle Scholar
  9. 9.
    Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN (1998) Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 101:1581–1590PubMedCrossRefGoogle Scholar
  10. 10.
    Himmelfarb J (2004) Linking oxidative stress and inflammation in kidney disease: which is the chicken and which is the egg? Seminal Dial 17:449–454CrossRefGoogle Scholar
  11. 11.
    Cole TJ, Green PJ (1992) Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med 11:1305–1319PubMedCrossRefGoogle Scholar
  12. 12.
    Kotur-Stevuljevic J, Memon L, Stefanovic A, Spasic S, Spasojevic-Kalimanovska V, Bogavac-Stanojevic N, Kalimanovska-Ostric D, Jelić-Ivanovic Z, Zunic G (2007) Correlation of oxidative stress parameters and inflammatory markers in coronary artery disease patients. Clin Biochem 40:181–187PubMedCrossRefGoogle Scholar
  13. 13.
    Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B (1996) Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304–1313PubMedCrossRefGoogle Scholar
  14. 14.
    Misra HP, Fridovich I (1972) The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 247:3170–3175PubMedGoogle Scholar
  15. 15.
    Ellman E (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–77PubMedCrossRefGoogle Scholar
  16. 16.
    Erel O (2004) A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 37:112–119PubMedCrossRefGoogle Scholar
  17. 17.
    Hamidi Alamdari D, Ghayour-Mobarhan M, Tavallaie S, Reza Parizadeh M, Moohebati M, Ghafoori F, Kazemi-Bajestani SMR, Paletas K, Pegiou T, Koliakos G (2008) Prooxidant–antioxidant balance as a new risk factor in patients with angiographically defined coronary artery disease. Clin Biochem 41:375–380CrossRefGoogle Scholar
  18. 18.
    Richter RJ, Furlong CE (1999) Determination of paraoxonase (PON1) status requires more than genotyping. Pharmacogenetics 9:745–753PubMedCrossRefGoogle Scholar
  19. 19.
    Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA (1998) Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: Bogalusa Heart study. N Engl J Med 338:1650–1656PubMedCrossRefGoogle Scholar
  20. 20.
    Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, Vasan RS, Ramachandran S, O’Donnell CJ, Fox CS (2008) Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 117:605–613PubMedCrossRefGoogle Scholar
  21. 21.
    Kalantar-Zadeh K, Kopple JD (2006) Obesity paradox in patients on maintenance dialysis. Contrib Nephrol 151:57–69PubMedCrossRefGoogle Scholar
  22. 22.
    Elsayed EF, Sarnak MJ, Tighiouart H, Griffith JL, Kurth T, Salem DN, Levey AS, Weiner DE (2008) Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis 52:29–38PubMedCrossRefGoogle Scholar
  23. 23.
    Rashid R, Neill E, Smith W, King D, Beattie TJ, Murphy A, Ramage IJ, Maxwell H, Ahmed SF (2006) Body composition and nutritional intake in children with chronic kidney disease. Pediatr Nephrol 21:1730–1738PubMedCrossRefGoogle Scholar
  24. 24.
    Flynn JT (2006) Cardiovascular disease in children with chronic renal failure. Growth Horm IGF Res 16:84–90CrossRefGoogle Scholar
  25. 25.
    Chen X, Burton C, Song X, McNamara L, Langella A, Cianetti S, Chang CH, Wang J (2009) An apoA-I mimetic peptide increases LCAT activity in mice through increasing HDL concentration. Int J Biol Sci 5:489–499PubMedCrossRefGoogle Scholar
  26. 26.
    Bergstrom J (1995) Nutrition and mortality in hemodialysis. J Am Soc Nephrol 6:1329–1341PubMedGoogle Scholar
  27. 27.
    Ikizler TA, Lara L, Pupim B, Brouillette JR, Levenhagen DK, Farmer K, Hakim RM, Flakoll PJ (2002) Hemodialysis stimulates muscle and whole body protein loss and alters substrate oxidation. Am J Physiol Endocrinol Metab 282:107–116Google Scholar
  28. 28.
    Sass C, Herbeth B, Chapel O, Siest G, Visvikis S, Zannad F (1998) Intima-media thickness and diameter of carotid and femoral arteries in children, adolescents and adults from the Stanislas cohort: Effect of age, sex, anthropometry and blood pressure. J Hypertens 16:1593–1602PubMedCrossRefGoogle Scholar
  29. 29.
    Böhm B, Hartmann K, Buck M, Oberhoffer R (2009) Sex differences of carotid intima-media thickness in healthy children and adolescents. Atherosclerosis 206:458–463PubMedCrossRefGoogle Scholar
  30. 30.
    Jourdan C, Wühl E, Litwin M, Fahr K, Trelewicz J, Jobs K, Schenka JP, Grenda R, Mehls O, Tröger J, Schaefer F (2005) Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents. J Hypertens 23:1707–1715PubMedCrossRefGoogle Scholar
  31. 31.
    Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100–105PubMedCrossRefGoogle Scholar
  32. 32.
    Kari JA, Donald AE, Vallance DT, Bruckdorfer KR, Leone A, Mullen MJ, Bunce T, Dodo B, Deanfield JE, Rees L (1997) Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int 52:468–472PubMedCrossRefGoogle Scholar
  33. 33.
    Pawlak K, Pawlak D, Mysliwiec M (2007) Impaired renal function and duration of dialysis therapy are associated with oxidative stress and proatherogenic cytokine levels in patients with end-stage renal disease. Clin Biochem 40:81–85PubMedCrossRefGoogle Scholar
  34. 34.
    Ece A, Atamer Y, Gurkan F, Davutoğlu M, Bilici M, Tutanç M, Güneş A (2006) Paraoxonase, anti-oxidant response and oxidative stress in children with chronic renal failure. Pediatr Nephrol 21:239–245PubMedCrossRefGoogle Scholar
  35. 35.
    Cengiz N, Baskin E, Sezgin N, Agras P, Haberal M (2009) Oxidative stress in children on hemodialysis: value of autoantibodies against oxidized low-density lipoprotein. Pediatr Nephrol 24:387–393PubMedCrossRefGoogle Scholar
  36. 36.
    Ece A, Gürkan F, Kervancıoğlu M, Kocamaz H, Güneş A, Atamer Y, Selek Ş (2006) Oxidative stress, inflammation and early cardiovascular damage in children with chronic renal failure. Pediatr Nephrol 21:545–552PubMedCrossRefGoogle Scholar
  37. 37.
    Parhami F, Basseri B, Hwang J, Tintut Y, Demer LL (2002) High density lipoprotein regulates calcification of vascular cells. Circ Res 91:570–576PubMedCrossRefGoogle Scholar
  38. 38.
    Gugliucci A, Kinugasa E, Kotani K, Caccavello R, Kimura S (2011) Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysis. Clin Chem Lab Med 49:61–67PubMedCrossRefGoogle Scholar

Copyright information

© IPNA 2012

Authors and Affiliations

  • Jelena Kotur-Stevuljević
    • 1
  • Amira Peco-Antić
    • 2
    • 3
  • Slavica Spasić
    • 1
  • Aleksandra Stefanović
    • 1
  • Dušan Paripović
    • 2
    • 3
  • Mirjana Kostić
    • 3
  • Dragan Vasić
    • 2
    • 4
  • Ana Vujović
    • 1
  • Zorana Jelić-Ivanović
    • 1
  • Vesna Spasojević-Kalimanovska
    • 1
  • Danijela Kornic-Ristovski
    • 5
  1. 1.Department for Medical Biochemistry, Faculty of PharmacyUniversity of BelgradeBelgradeSerbia
  2. 2.Medical FacultyUniversity of BelgradeBelgradeSerbia
  3. 3.Department of NephrologyUniversity Children’s HospitalBelgradeSerbia
  4. 4.Vascular Surgery Clinic, Institute for Cardiovascular DiseasesClinical Centre of SerbiaBelgradeSerbia
  5. 5.Biochemical LaboratoryHealth Centre PančevoPančevoSerbia

Personalised recommendations